NMDA receptor-mediated extracellular adenosine accumulation in rat forebrain neurons in culture is associated with inhibition of adenosine kinase

European Journal of Neuroscience

Volumn 17, Issue 6, 2003, Pages 1213-1222

  Lu, Yin ^a   Chung, Hye Joo ^a,b   Li, Ya ^a   Rosenberg, Paul A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE KINASE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM ION; CYCLIC GMP; CYCLIC GMP DERIVATIVE; DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TUBERCIDIN DERIVATIVE;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; BRAIN MITOCHONDRION; CALCIUM TRANSPORT; CHELATION; ENZYME ACTIVITY; ENZYME INHIBITION; EVOKED RESPONSE; EXTRACELLULAR SPACE; FOREBRAIN; HYDROLYSIS; MOLECULAR MIMICRY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOSINE; ADENOSINE KINASE; ANIMALS; CELL CULTURE TECHNIQUES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC GMP; EXTRACELLULAR SPACE; NEURONS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0037361942     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02554.x     Document Type: Article

References (98)

1. Arch., J.R. & Newsholme, E.A. (1978) The control of the metabolism and the hormonal role of adenosine. Essays Biochem., 14, 82-123.
2. Arrigoni, E., Rainnie, D.G., McCarley, R.W. & Greene, R.W. (2001) Adenosine-mediated presynaptic modulation of glutamatergic transmission in the laterodorsal tegmentum. J. Neurosci., 21, 1076-1085.
3. Baldwin, S.A., Mackey, J.R., Cass, C.E. & Young, J.D. (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol. Med. Today, 5, 216-224.
4. Barber, R. & Butcher, R.W. (1983) The egress of cyclic AMP from metazoan cells. Adv. Cyclic Nucleotide Res., 15, 119-138.
5. Benington, J.H. & Heller, H.C. (1995) Restoration of brain energy metabolism as the function of sleep. Prog. Neurobiol., 45, 347-360.
6. Benowitz, L.I., Jing, Y., Tabibiazar, R., Jo, S.A., Petrausch, B., Stuermer, C.A., Rosenberg, P.A. & Irwin, N. (1998) Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J. Biol. Chem., 273, 29626-29634.
7. Bischofberger, N., Jacobson, K.A. & vonLubitz, D.K.J.E. (1997) Adenosine A (1) receptor agonists as clinically viable agents for treatment of ischemic brain disorders. Ann. NY Acad. Sci., 825, 23-29.
8. Bonci, A. & Williams, J.T. (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron, 16, 631-639.
9. Bontemps, F., Van den Berghe, G. & Hers, H.G. (1983) Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc. Natl. Acad. Sci. USA, 80, 2829-2833.
10. Boulton, C.L., Irving, A.J., Southam, E., Potier, B., Garthwaite, J. & Collingridge, G.L. (1994) The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci., 6, 1528-1535.
11. Brand, A., Vissiennon, Z., Eschke, D. & Nieber, K. (2001) Adenosine A (1) and A (3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology, 40, 85-95.
12. Broome, M.R., Collingridge, G.L. & Irving, A.J. (1994) Activation of the NO-cGMP signalling pathway depresses hippocampal synaptic transmission through an adenosine receptor-dependent mechanism. Neuropharmacology, 33, 1511-1513.
13. Brundege, J.M. & Dunwiddie, T.V. (1996) Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J. Neurosci., 16, 5603-5612.
14. Brundege, J.M. & Dunwiddie, T.V. (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol., 39, 353-391.
15. Buck, L.T. & Bickler, P.E. (1998) Adenosine and anoxia reduce N-methyl-D-aspartate receptor open probability in turtle cerebrocortex. J. Exp. Biol., 201, 289-297.
16. Budd, S.L., Tenneti, L., Lishnak, T. & Lipton, S.A. (2000) Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA, 97, 6161-6166.
17. Burke, L.P. & Nadler, J.V. (1988) Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effect of adenosine and baclofen. J. Neurochem., 51, 1541-1551.
18. Chen, Y., Graham, D.I. & Stone, T.W. (1992) Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br. J. Pharmacol., 106, 632-638.
19. Connick, J.H. & Stone, T.W. (1989) Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyl-adenosine (PIA) and potentiation by hypotension. Neurosci. Lett., 101, 191-196.
20. Costenla, A.R., De Mendonca, A., Sebastiao, A. & Ribeiro, J.A. (1999) An adenosine analogue inhibits NMDA receptor-mediated responses in bipolar cells of the rat retina. Exp. Eye Res., 68, 367-370.
21. Craig, C.G. & White, T.D. (1993a) N-methyl-D-aspartate- and non-N-methyl-D-aspartate-evoked adenosine release from rat cortical slices: distinct purinergic sources and mechanisms of release. J. Neurochem., 60, 1073-1080.
22. Craig, C.G. & White, T.D. (1993b) NMDA-evoked adenosine release from rat cortex does not require the intermediate formation of nitric oxide. Neurosci. Lett., 158, 167-169.
23. Cunha, R.A., Brendel, P., Zimmermann, H. & Ribeiro, J.A. (2000) Immunologically distinct isoforms of ecto-5′-nucleotidase in nerve terminals of different areas of the rat hippocampus. J. Neurochem., 74, 334-338.
24. Dalpiaz, A. & Manfredini, S. (2002) Adenosine A (1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system. Curr. Med. Chem., 9, 1923-1937.
25. Davies, L.P., Jamieson, D.D., Baird-Lambert, J.A. & Kazlauskas, R. (1984) Holagenated pyrrolopyrimidine analogues of adenosine from marine organisms: Pharmacological activities and potent inhibition of adenosine kinase. Biochem. Pharm., 33, 347-355.
26. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S. & Snyder, S.H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA, 88, 6368-6371.
27. De Mendonca, A., Sebastiao, A.M. & Ribeiro, J.A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Rev., 33, 258-274.
28. Dolphin, A.C. & Archer, E.R. (1983) An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett., 43, 49-54.
29. Dragunow, M. & Faull, R.L.M. (1988) Neuroprotective effects of adenosine. Trends Neurosci., 9, 193-194.
30. Dunwiddie, T.V. (1985) The physiological role of adenosine in the central nervous system. Int. Rev. Biochem., 27, 63-139.
31. Dunwiddie, T.V., Dial, L. & Protor, W.R. (1997) Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci., 17, 7673-7682.
32. Edwards, F.A. (1996) Features of P2X receptor-mediated synapses in the rat brain: why doesn't ATP kill the postsynaptic cell? CIBA Found. Symp., 198, 278-289.
33. Fallahi, N., Broad, R.M., Jin, S. & Fredholm, B.B. (1996) Release of adenosine from rat hippocampal slices by nitric oxide donors. J. Neurochem., 67, 186-193.
34. Garthwaite, J., Garthwaite, G., Palmer, R.M.J. & Moncada, S. (1989) NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol., 172, 413-416.
35. Geiger, J., Nolte, C., Butt, E., Sage, S.O. & Walter, U. (1992) Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc. Natl. Acad. Sci. USA, 89, 1031-1035.
36. Gereau, R.W. 4th & Conn, P.J. (1994) Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron, 12, 1121-1129.
37. Gerevich, Z., Wirkner, K. & Illes, P. (2002) Adenosine A (2A) receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur. J. Pharmacol., 451, 161-164.
38. Goldberg, M.P., Monyer, H., Weiss, J.H. & Choi, D.W. (1988) Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro. Neurosci. Lett., 89, 323-337.
39. Golembiowska, K., White, T.D. & Sawynok, J. (1996) Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur. J. Pharmacol., 307, 157-162.
40. Greene, R.W. & Haas, H.L. (1991) The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol., 36, 329-341.
41. Hebb, M.O. & White, T.D. (1998) Co-administration of adenosine kinase and deaminase inhibitors produces super-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex. Eur. J. Pharm., 344, 121-125.
42. Hoehn, K. & White, T.D. (1988) Evoked release of endogenous adenosine from rat cortical slices by K+ and glutamate. Brain Res., 478, 49-51.
43. Hoehn, K. & White, T.D. (1990a) Glutamate-evoked release of endogenous adenosine from rat cortical synaptosomes is mediated by glutamate uptake and not by receptors. J. Neurochem., 54, 1716-1724.
44. Hoehn, K. & White, T.D. (1990b) N-methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices. Neuroscience, 39, 441-450.
45. +- and glutamate-evoked release of endogenous adenosine from rat cortical slices. J. Neurochem., 54, 256-265.
46. Huang, C.C., Liang, Y.C. & Hsu, K.S. (1999) A role for extracellular adenosine in time-dependent reversal of long-term potentiation by low-frequency stimulation at hippocampal CA1 synapses. J. Neurosci., 22, 9728-9738.
47. Huston, J.P., Haas, H.L., Boix, F., Pfister, M., Decking, U., Scharader, J. & Schwarting, R.K.W. (1996) Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats. Neuroscience, 73, 99-107.
48. Jackisch, R., Strittmatter, H., Kasakov, L. & Hertting, G. (1984) Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch. Pharmacol., 327, 319-325.
49. Kitagawa, H., Mori, A., Shimada, J., Mitsumoto, Y. & Kikuchi, T. (2002) Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats. Neurol. Res., 24, 317-323.
50. Lipton, S.A. & Rosenberg, P.A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med., 330, 613-622.
51. Lloyd, H.G.E. & Fredholm, B.B. (1995) Involvement of adenosine deaminase and adenosine kinase in regulating adenosine concentration in rat hippocampal slices. Neurochem. Int., 26, 387-395.
52. 1 receptor agonist. Eur. J. Pharmacol., 369, 313-317.
53. Lynch, J.J. III, Alexander, K.M., Jarvis, M.F. & Kowaluk, E.A. (1998) Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures. Neurosci. Lett., 252, 207-210.
54. MacDermott, A.B., Mayer, M.L., Westbrook, G.L., Smith, S.J. & Barker, J.L. (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature, 321, 519-522.
55. Manzoni, O., Manabe, T. & Nicoll, R.A. (1994) Release of adenosine by activation of NMDA receptors in the hippocampus. Science, 265, 2098-2101.
56. Mathews, I.I., Erion, M.D. & Ealick, S.E. (1998) Structure of human adenosine kinase at 1.5 A resolution. Biochemistry, 37, 15607-15620.
57. McIlwain, H. & Poll, J.D. (1986) Adenosine in cerebral homeostatic role: appraisal through actions of homocysteine, colchicine, and dipyridamole. J. Neurobiol., 17, 39-49.
58. McNally, T., Helfrich, R.J., Cowart, M., Dorwin, S.A., Meuth, J.L., Idler, K.B., Klute, K.A., Simmer, R.L., Kowaluk, E.A. & Halbert, D.N. (1997) Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem. Biophys. Res. Comm., 231, 645-650.
59. Meldrum, B. & Garthwaite, J. (1990) Excitatory amino acid neurotoxicity and neurodegerative disease. Trends Pharmacol. Sci., 11, 379-387.
60. Miller, R.L., Adamczyk, D.L. & Miller, W.H. (1979) Adenosine kinase from rabbit liver. I. Purification by affinity chromatography and properties. J. Biol. Chem., 254, 2339-2345.
61. Mitchell, J.B., Lupica, C.A. & Dunwiddie, T.V. (1993) Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci., 13, 3439-3447.
62. Mori, M., Nishizaki, T. & Okada, Y. (1992) Protective effect of adenosine on the anoxic damage of hippocampal slices. Neuroscience, 46, 301-307.
63. Moriwaki, Y., Yamamoto, T. & Higashino, K. (1999) Enzymes involved in purine metabolism - a review of histochemical localization and functional implications. Histol. Histopathol., 14, 1321-1340.
64. Norenberg, W., Wirkner, K., Assmann, H., Richter, M. & Illes, P. (1998) Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons. Amino Acids, 14, 33-39.
65. Nowak, L., Bregestovski, P., Ascher, P., herbet, A. & Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurons. Nature, 307, 462-465.
66. Obata, T. & Yamanaka, Y. (2000) Reserpine attenuates interstitial adenosine-mediated activation of ecto-5′-nucleotidase in rat hearts in vivo. Arch. Biochem. Biophys., 375, 333-339.
67. Pak, M.A., Haas, H.L., Decking, U.K. & Schrader, J. (1994) Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology, 33, 1049-1053.
68. Palella, T.D., Andres, C.M. & Fox, I.H. (1980) Human placental adenosine kinase. Kinetic mechanism and inhibition. J. Biol. Chem., 225, 5264-5269.
69. Parkinson, F.E. & Geiger, J.D. (1996) Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells. J. Pharmacol. Exp. Ther., 277, 1397-1401.
70. + depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur. J. Pharmacol., 234, 61-65.
71. Pedata, F., Latini, S., Pugliese, A.M. & Pepeu, G. (1993) Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J. Neurochem., 61, 284-289.
72. 6-etheno derivatives by reversed-phase ion-pair high performance liquid chromatography. J. Chromatogr., 386, 289-296.
73. Phillis, J.W., Kostopoulos, K. & Limacher, I. (1974) A potent depressant action of adenine derivatives on cerebral cortical neurons. Eur. J. Pharmacol., 30, 125-129.
74. Porkka-Heiskanen, T., Strecker, R.E., Thakkar, M., Bjorkum, A.A., Greene, R.W. & McCarley, R.W. (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science, 276, 1265-1268.
75. Portas, C.M., Thakkar, M., Rainnie, D.G., Greene, R.W. & McCarley, R.W. (1997) Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience, 79, 225-235.
76. 6-(-L-Phenylisopropyl) adenosine (L-PIA) increases slow-wave sleep (S2) and decreases wakefulness in rats. Brain Res., 246, 178-180.
77. Radulovacki, M., Virus, R.M., Djuricic-Nedelson, M. & Green, R.D. (1983) Hypnotic effects of deoxycorformycin in rates. Brain Res., 271, 392-395.
78. Radulovacki, M., Virus, R.M., Djuricic-Nedelson, M. & Green, R.D. (1984) Adenosine analogs and sleep in rats. J. Pharmacol. Exp. Ther., 228, 268-274.
79. Rainnie, D.G., Grunze, H.C., McCarley, R.W. & Greene, R.W. (1994) Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science, 263, 689-692.
80. Reeves, M.L., Leigh, B.K. & England, P.J. (1987) The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem. J., 241, 535-541.
81. Rosenberg, P.A. (1992) Functional significance of cyclic AMP secretion in cerebral cortex. Brain Res. Bull., 29, 315-318.
82. Rosenberg, P.A. & Dichter, M.A. (1989) Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. J. Neurosci., 9, 2654-2663.
83. Rosenberg, P.A., Knowles, R., Knowles, K.P. & Li, Y. (1994) Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci., 14, 2953-2965.
84. Rosenberg, P.A. & Li, Y. (1995a) Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extra-cellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res., 692, 227-232.
85. Rosenberg, P.A. & Li, Y. (1995b) Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neurosci. Lett., 200, 93-96.
86. Rosenberg, P.A. & Li, Y. (1996) Forskolin evokes extracellular adenosine accumulation in rat cortical cultures. Neurosci. Lett., 211, 49-52.
87. Rosenberg, P.A., Li, Y., Le, M. & Zhang, Y. (2000) Nitric oxide stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity. J. Neurosci., 20, 6294-6301.
88. Rothman, S.M. & Olney, J.W. (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci., 10, 299-302.
89. Rotllan, P. & Miras Portugal, M.T. (1985) Adenosine kinase from bovine adrenal medulla. Eur. J. Biochem., 151, 365-371.
90. Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P. & Honore, J. (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline: a neuroprotectant for cerebral ischemia. Science, 247, 571-574.
91. Sheppard, H., Wiggan, G. & Tsien, W.H. (1972) Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues. Adv. Cyclic Nucleotide Res., 1, 103-112.
92. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K. Gartner, F.H., Provenzano, M.D., Fujimoto, E.K, Goeke, N.M., Olson, B.J. & Klenk, D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
93. Stone, T.W., Newby, A.C. & Lloyd, H.G.E. (1990) Adenosine release. In: Williams, M. (ed.) Adenosine and Adenosine Receptors. The Humana Press, New Jersey, pp. 173-223.
94. Wang, G.J., Chung, H.J., Schnuer, J., Pratt, K., Zable, A.C., Kavanaugh, M.P. & Rosenberg, P.A. (1998) High affinity glutamate transport in rat cortical neurons in culture. Mol. Pharm., 53, 96.
95. White, T.D. (1996) Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine. Eur. J. Pharm., 303, 27-38.
96. White, T.D., Craig, C.G. & Hoehn, K. (1993) Extracellular adenosine, formed during low-level NMDA receptor activation, provides an inhibitory threshold against further NMDA receptor-mediated neurotransmission in the cortex. Drug Dev. Res., 28, 406-409.
97. Wirkner, K., Assmann, H., Koles, L., Gerevich, Z., Franke, H., Norenberg, W., Boehm, R. & Illes, P. (2000) Inhibition by adenosine A (2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons. Br. J. Pharmacol., 130, 259-269.
98. Zhang, H., Dawson, V.L., Dawson, T.M. & Snyder, S.H. (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science, 263, 687-689.